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Xeroderma pigmentosum (XP)A gene-deﬁcient mice display dermatologic abnormalities similar to human XP, such
as enhanced ultraviolet (UV)-induced acute inﬂammation and high incidence of UVB-induced skin cancer. We have
previously reported that UVB-induced immunosuppression of contact hypersensitivity was greatly enhanced in
XPA mice. In the present study, we examined the effects of UVB radiation on tumor rejection in XPA mice. Tumor
cells established from UVB-induced squamous cell carcinoma in XPA mice were injected subcutaneously. No
difference in the development of tumors was observed between the non-irradiated XPA and wild-type mice. Tumors
developed, grew in size, and reached the maximum at 7–10 d after the inoculation. Thereafter, all tumors decreased
in size and were completely rejected by 4 wk in both strains of mice. When tumor cells were inoculated into the skin
that had been irradiated with 50–150 mJ per cm2 of UVB, tumor grew in 60% (12 of 20) of the XPA mice, but only in
4% (one of 23) of wild-type mice. Phenotyping of tumor-inﬁltrating cells revealed that the migration of natural killer
cells and CD8(þ ) T cells was inhibited in UVB-irradiated XPA mice. These data suggest that enhanced UVB-
induced impairment of tumor rejection could be partially involved in the cancer development of XP patients.
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The tumor immunity plays an important role in the devel-
opment, growth, and metastasis of cancer cells and is a
major defense strategy against neoplasms. It is now gen-
erally accepted that ultraviolet (UV) B radiation has mu-
tagenic properties and also immunosuppressive effects,
which may contribute to the development of sunlight-
induced skin cancers (Streilein et al, 1994; Berneburg and
Krutmann, 2000). Underlying mechanisms of UV-induced
immunosuppression have been extensively studied in T cell-
mediated immune reactions including contact hypersensi-
tivity (CHS) and delayed type of hypersensitivity (DTH)
(Noonan et al, 1981; Ullrich et al, 1986; Miyauchi and Horio,
1995). The UVB irradiation before the sensitizing procedure
can induce hapten- or antigen-specific suppressor or reg-
ulatory T cells, resulting in tolerance to the sensitizer (Shree-
dar et al, 1998; Moodycliffe et al, 2000; Schwarz et al, 2000).
Therefore, the affected animals cannot be re-sensitized with
the same antigen at a later time without further irradiation,
but can be sensitized to other unrelated antigens. Depletion
or dysfunction of antigen-presenting cells and production of
a variety of cytokines or soluble factors with immunomod-
ulatory activity may be involved in the UV-induced immuno-
suppression.
There is strong evidence that DNA damage in the skin
plays a crucial role in the UV-induced immunosuppression
of CHS and DTH. The initial studies were performed using
the marsupial Monodelphis domestica, whose cells have a
photolyase DNA repair enzyme that is activated to repair
cyclobutane pyrimidine dimers (CPD) by exposure to photo-
reactivating visible light. Photo-repair of UVB-induced CPD
restored suppression of the CHS response in the animal
(Applegate et al, 1989). Furthermore, topical treatment with
liposomes containing the excision repair enzyme T4 end-
onuclease V prevented UVB-induced suppression of CHS
and DTH responses (Kripke et al, 1992). We have previously
studied the effects of UVB on the immunologic function of
xeroderma pigmentosum (XP)A gene-deficient mice that
have defects in nucleotide excision repair. Although CHS
was induced in non-irradiated XPA mice as well as wild-type
mice, UVB-induced local and systemic immunosuppress-
ions were greatly enhanced in XPA mice (Miyauchi-Hashi-
moto et al, 1996). There are some studies that patients with
XP have defects in cell-mediated immunity such as im-
paired cutaneous responses to recall antigens and a con-
tact sensitizer (Morison et al, 1985; Wysenbeek et al, 1986;
Goldstein et al, 1990). Our studies using XPA mice sug-
gested that the immunologic dysfunction in XP patients
is not innate but acquired possibly after exposures to the
sunlight. We have also investigated the natural killer cells,
which play a crucial role in antigen non-specific tumor im-
munity, and found that XPA mice displayed a higher level of
spontaneous and polyisosinic:polycytidylic acid-inducible
natural killer cell activity than wild-type mice, unless they
were exposed to UVB. But, the activity in XPA mice was
impaired by UVB irradiation at doses that did not affect the
natural killer activity in wild-type mice (Miyauchi-Hashimoto
et al, 1999). These results strongly suggest that UV-induced
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DNA damage is responsible not only for gene mutations but
also for immunologic impairment, and thereby skin cancers
developed especially in XP patients. To address this issue,
in the present experiments, we examined the effects of UVB
radiation on the tumor immunity in XPA mice.
Results
UVB inhibited rejection of transplanted squamous cell
carcinoma (SCC) cells from XPA mice First, 3  107 of
tumor cells were inoculated into the skin of non-irradiated
recipient mice (eight wild-type and eight XPA mice) and the
time course of the size of tumors was examined. There was
no difference in development of tumors between non-irra-
diated wild-type and XPA mice. In both types of mice,
tumors inoculated into non-irradiated skin grew in size, and
reached the maximum at 7 or 10 d after the inoculation.
Thereafter, all tumors decreased in size and were rejected
by 4 wk after the inoculation in both strains of mice (Fig 1).
Next, the effect of UVB irradiation on the ability to reject
inoculated tumor cells was examined. One group of mice
(four each of wild-type and XPA mice) was irradiated with
25 mJ per cm2 UVB for 2 d. The second group (six of wild-
type and five of XPA mice) received single irradiation with
100 mJ per cm2 UVB. The third group (13 of wild-type and
11 of XPA mice) was exposed to 75 mJ per cm2 on 2 con-
secutive days. Therefore, each group was exposed totally
to 50, 100, and 150 mJ per cm2, respectively. One day after
the last irradiation, 3  107 of SCC tumor cells were inoc-
ulated into the irradiated skin. When exposed to 150 mJ per
cm2-UVB, the tumor volume increased after the inoculation,
and reached a maximum at day 25 in XPA mice (Fig 2). The
macroscopic features of mice at day 17 after tumor inoc-
ulation into 150 mJ per cm2-UVB irradiated skin are shown
in Fig 2B. Tumors in wild-type mice had already subsided
whereas those in XPA mice were growing with central ne-
crosis. Almost the same results were observed in the ex-
periment in which tumor cells were inoculated into the skin
irradiated with 50 and 100 mJ per cm2-UVB (data not
shown). When tumors were engrafted into the skin exposed
to 150 mJ per cm2-UVB, the percentage of tumor-bearing
wild-type mice decreased by day 12 after the inoculation,
and there are no mice having tumors on day 42. In contrast,
55% of XPA mice had tumors even on day 42. The number
of tumor-bearing mice at the sixth wk is summarized in
Table I. When mice were exposed to 50, 100, or 150 mJ per
cm2-UVB, 75% (three of four), 60% (three of five), or 55%
(six of 11) of XPA mice, respectively, maintained the tumors,
but almost all tumors had been rejected by wild-type mice
at the sixth wk.
Histological examination showed proliferation of in-
oculated tumor cells in UVB-irradiated skin of XPA
mice Histological study was performed in three mice each
Figure 1
Tumors developed and were rejected from the skin in which cul-
tured tumor cells were inoculated. The cell line was derived from
squamous cell carcinoma that had been induced by chronic ultraviolet
B irradiation in xeroderma pigmentosum (XP)A mice. A suspension of
3  107 tumor cells was injected subcutaneously into non-irradiated
XPA and wild-type mice (n¼8 each). Tumor size was measured pe-
riodically after inoculation. Tumor volume was calculated as transverse
diameter  right-angled diameter  height (mm3). The results are pre-
sented as mean  SD. Significant difference with p¼ 0.02.
Figure2
Ultraviolet (UV) B radiation suppressed rejection of transplanted
tumor cells from xeroderma pigmentosum (XP)A mice. Mice were
exposed to UVB at a dose of 75 mJ per cm2 for 2 consecutive days.
One day after the second exposure, a suspension of 3  107
squamous cell carcinoma was injected subcutaneously into UVB-irra-
diated XPA (n¼11) and wild-type mice (n¼ 13). Tumor volume was
measured after irradiation (A). The results are presented as mean  SD.
,  Significant differences with p¼ 0.05 and po0.0001, respectively.
Seventeen days after tumor cell inoculation, wild-type mice completely
rejected tumors, whereas XPA mice had large tumors (B).
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of wild-type and XPA mice at various time points after tumor
cell inoculation into the skin irradiated with 150 mJ per cm2-
UVB. In wild-type mice, tumor masses proliferated in the
subcutaneous tissue at day 9 after the inoculation. At day
12, marked inflammatory cells including mononuclear cells,
neutrophils, and eosinophils infiltrated in and around tumor
masses, and tumor masses revealed necrotic change. At
day 16, tumor masses were almost replaced with necrotic
tissue and keratin materials with calcification, and were
surrounded by fibrosis and granulation. In XPA mice, tumor
masses revealed necrotic change surrounded by inflamma-
tory cells in subcutaneous tissue, but a small part of tumor
masses proliferated up to the dermis breaking down to the
muscle at day 9. Remaining tumor cells proliferated at day
12 associated with prominent inflammatory cells infiltrated
around tumor masses. At day 16, tumor masses were fur-
ther proliferating progressively into the upper part of the
dermis associated with inflammatory cell infiltration.
Flow cytometric analysis of tumor-inﬁltrating cells Tu-
mors were removed at various time points after inoculation
of 3  107 SCC cells in the skin exposed to 150 mJ (75
mJ  2) per cm2. The number of tumor-infiltrating cells,
separated from tumor suspensions by centrifugation with
Histopaque (Sigma, St Louis, Missouri), was counted, and
the cells were phenotyped by flow cytometry. In wild-type
mice, the size of tumors peaked on day 12 after tumor cell
inoculation and decreased thereafter. But, the total number
of tumor-infiltrating cells was maintained at the peak even
after the tumor size had begun to decrease (Fig 3). On the
other hand, the peak of the number of tumor-infiltrating cells
in XPA mice was delayed, reached at day 21, and thereafter
decreased rapidly although tumor size was increasing. The
time course of infiltration of NK cells in wild-type mice was
similar to that of whole infiltrating cells, reaching the max-
imum at day 12 and decreasing thereafter. But, only a few
NK cells infiltrated into the tumors in XPA mice throughout
the period of observation. In wild-type mice, infiltration of
CD3(þ ) lymphocytes into the tumors increased until day
19, 1 wk after the peak of infiltration of NK cells. A few days
after the peak of tumor size, the amount of infiltrating
CD3(þ ) cells decreased. The timing and the level of peak of
infiltrating CD8(þ ) T cells in wild-type mice were almost
identical to those of CD3(þ ) cells, suggesting that a large
part of tumor-infiltrating lymphocytes was CD8(þ ) T cells
with possible cytotoxicity to tumor cells. The infiltration of
CD4(þ ) T cells delayed and was at a low level. In XPA mice,
infiltration of CD3(þ ), especially CD8(þ ) cells, was slight in
early phase of the tumor growth. The infiltrating CD3(þ ) and
CD4(þ ) cells increased and reached maximum in the later
phase.
Discussion
We previously demonstrated that UVB-induced local and
systemic immunosuppression of CHS to hapten was
enhanced in XPA mice that have a defect in nucleotide
excision repair of DNA lesions (Miyauchi-Hashimoto et al,
1996). Moreover, UVB-induced suppression of NK cell ac-
tivity was also enhanced in XPA mice (Miyauchi-Hashimoto
et al, 1999). These findings suggested that UVB-induced
DNA damage is one of the primary molecular mechanisms
that leads to the suppression of cell-mediated immunolog-
Table I. UVB effect on the rejection of tumor cells
Group
UVB treatment,
total dose (dose  d)
Tumor
incidencea
at 6 wk
Wild-type XPA mice
I 50 mJ per cm2
(25 mJ per cm2  2)
0/4 3/4
II 100 mJ per cm2
(100 mJ per cm2  1)
1/6 3/5
III 150 mJ per cm2
(75 mJ per cm2  2)
0/13 6/11
Total 1/23 12/20b
aNumber of tumor-bearing mice/number of challenged mice.
bSignificant difference with p¼ 0.002.
UVB, ultraviolet B, XPA, xeroderma pigmentosum A.
Figure3
Flow cytometric analysis of tumor-infiltrating cells. Tissues for
analysis were obtained from tumors that developed in wild-type and
xeroderma pigmentosum A (XP)A mice as described in Fig 2. Tumor-
infiltrating cells were prepared as described in Materials and Methods.
Number and phenotypes of tumor infiltrating cells were analyzed by
flow cytometry. Statistical analysis and error bars are not provided,
because the experiment was performed only once using four tumors
(one per mouse).
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ical responses. It is well established that the tumor immunity
plays an extremely important role in regulating the growth
and metastasis of tumors. Especially, cell-mediated immu-
nological reactions play a crucial role in tumor immunity.
Thus, to examine directly whether UVB-induced DNA dam-
age is involved in the impairment of immunological reac-
tions against tumors, the effects of UVB radiation on tumor
rejection were compared between XPA (/) and wild-type
mice.
In this study, there was no difference in the ability to
reject transplanted or inoculated tumors between wild-type
and XPA mice unless they were exposed to UVB. Kripke
et al demonstrated that UV-induced skin tumors that were
transplanted onto normal syngeneic mice revealed an im-
munological reaction leading to inhibition of tumor growth
and to tumor rejection, because such tumors have high an-
tigenicity, and that the tumor rejection was impaired by the
previous exposure of recipient mice (Kripke et al, 1977,
1994). In this study, however, tumors engrafted into the
UVB-irradiated skin of wild-type mice were rejected, sim-
ilarly to those engrafted to non-irradiated skin at least at the
UV doses examined. In contrast, rejection of tumors from
UVB-irradiated skin was significantly delayed and impaired
in XPA mice. The immunosuppression is UV concentration-
dependent. Therefore, wild-type mice would show the same
result as XPA mice at a higher dose of UVB. These findings
were compatible to our previous report about CHS to hap-
ten in XPA mice (Miyauchi-Hashimoto et al, 1996). The CHS
response to haptens applied topically was suppressed by
UV irradiation of the skin not only at the application site but
also distant from the sensitization. This systemic immune
suppression was not confirmed in the present UVB-irradi-
ated recipient skin.
Histological examinations in this study suggested that
inflammatory cells in the UVB-irradiated XPA mice do not
have potent effects to suppress tumor growth. We have
previously reported that the number of circulating NK cells
in the peripheral blood was decreased and the cytotoxic
activity of splenic NK cells was suppressed after exposures
to UVB at a dose of 500 mJ per cm2 for 3 consecutive days
in XPA (/) mice, but not in XPA (þ /þ ) mice (Miyauchi-
Hashimoto et al, 1999). In this study, only 150 mJ per cm2-
UVB was sufficient to suppress the infiltration of NK cells to
the tumor tissue in the skin.
A number of cytokines and chemical mediators are pro-
duced and released from the skin after UVB exposure. We
have shown that the production of prostaglandin (PG)E2,
interleukin (IL)-10, and TNF-a was greatly increased in XPA
mice after UVB exposure (Kuwamoto et al, 2000). These
immunosuppressive factors have antagonistic properties
against IFN-g, IL-2, and IL-12, which have an important role
in the proliferation and activation of NK cells (Ortaldo et al,
1981; Ortaldo and Longo, 1988). Actually, PGE2 and IL-10
suppress NK activity through the suppression of IFN-g and
IL-2 induction by Th1 cells, macrophages, and NK cells
(Koren and Leung, 1982; Lin et al, 1994).
In wild-type mice, whether or not exposed to UVB,
CD3(þ ) T cells infiltrated in tumors after the peak of NK cell
infiltration associated with the tumor growth. Majority of the
accumulated CD3(þ ) T cells was CD8(þ ) T cells possibly
with cytotoxic activity. In contrast, the infiltration of CD8(þ )
T cells was suppressed in irradiated XPA mice at the time.
Following the decrease in the CD8(þ ) T cells, the infiltration
of CD4(þ ) T cells predominated in the growing tumor, sug-
gesting that the later T cells might have suppressor or reg-
ulatory activity but not cytotoxic activity.
Seo et al (1998) analyzed the population of tumor-infil-
trating cells in implanted B16 melanoma cells, and showed
that NK, NKT, abT, and gdT cells transiently accumulated
soon after tumor cell implantation. They also demonstrated
that the NK and NKT cells that appeared at an early stage
exhibited cytotoxicity to tumor cells, whereas abT and gdT
cell populations inhibited the cytotoxic activity of NK and
NKT cells. Following the accumulation of these cells,
CD4(þ ) Th1 and CD8(þ ) cytotoxic T cells infiltrated into
tumors. These CD4(þ ) and CD8(þ ) T cells were demon-
strated to have cytotoxicity against tumor cells in an anti-
gen-specific manner.
In conclusion, this study indicated that the defect in ex-
cision repair of DNA damage is involved in the enhancement
of UVB-induced suppression of tumor immunity against skin
cancers in XPA mice. This work confirmed that UV-induced
DNA damage is not just an initiator but also a tumor pro-
motor. It is possible that hyperproduction of immunosup-
pressive factors in the skin by UVB radiation is responsible
for the impairment of anti-tumor activity of infiltrated cells.
The high incidence of skin cancers in XP patients may be
mainly because of frequent mutations of tumor suppressor
genes and oncogenes after UV irradiation. In addition, UV-
induced impairment of tumor immunity could be partially
involved in the cancer development.
Materials and Methods
Animals XPA gene-deficient mice with CBA, C57BL/6, and CD-1
chimeric genetic background (Nakane et al, 1995) were back-
crossed with hairless albino mice of the inbred strain Hos/HR-1,
which were supplied by Hoshino Experimental Animal Farm (Sa-
itama, Japan), and the resultant hairless XPA (/) and XPA (þ /þ )
mice were used in this study. All mice were female and 8–10 wk of
age at the beginning of each experiment, but within a single ex-
periment, all mice were age-matched. Each experimental panel
consisted of 4–18 mice. Animal experiments were approved by the
Kansai Medical University Subcommittee on Research Animal Care.
UV-irradiation The UVB source was a bank of six fluorescent
sunlamps (FL.20SE.30; Toshiba Medical Supply, Tokyo, Japan)
with an emission spectrum of 275–375 nm, mainly UVB range,
peaking at 305 nm. The irradiance of UVB was measured by a
radiometer (UVR-305/365(II); Toshiba Medical Supply).
Tumor cell line The UVB-induced SCC cell line (SCC 18) was
derived from tumor that was induced in XPA mice by chronic UVB
irradiation. Cells were maintained in minimal essential medium
supplemented with 10% heat-inactivated fetal bovine serum at
371C in a 5% CO2/air humidified atmosphere.
Inoculation of cultured tumor cells After establishment of
tumor cell line, 3  107 cells were suspended in 0.2 mL of phos-
phate-buffered saline (PBS) and injected into a recipient mouse
subcutaneously in each side of the upper back a day after the last
UVB-irradiation.
Tumor measurement Tumor incidence was defined as the
number of palpable tumors greater than 2 mm in diameter. Tumor
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size was calculated as transverse diameter  right-angled diam-
eter  height (mm3).
Histologic examination Biopsy specimens were taken 6, 9, 12,
and 16 d after inoculation of tumor cells and were stained with
hematoxylin and eosin.
Preparation of tumor-inﬁltrating cells and ﬂow cytometric
analysis SCC 18 cells (3  107) were inoculated subcutaneously
into recipient mice. Developed tumors were removed, cut into
small pieces, crushed gently, and then suspended in 10% PBS
through nylon mesh. Ten milliliters of the cell suspension applied on
5 mL of Histopaque 1083 (Sigma) were subjected to centrifugation
at 1000  g for 30 min at 201C. The cells at the interface were
collected, washed three times with PBS containing 2% FCS, and
used as tumor-infiltrating cells.
Tumor-infiltrating cells obtained from four tumors (one tumor
per mouse) were stained with FITC-and/or PE-conjugated mono-
clonal antibodies for 30 min at 41C, washed three times, and then
analyzed with a flow cytometer (FACScan, Becton Dickinson, Ox-
nard, California). The mononuclear cell fraction was gated to
exclude contaminating tumor cells, and data were displayed on
two-color plots or a histogram by FACScan programs. The fluo-
rescence intensity was visualized on a histogram by flow cyto-
metric analysis.
Monoclonal Abs The following monoclonal Abs were purchased
from PharMingen (San Diego, California): PE-conjugated anti-
NK1.1 (PK136), FITC-conjugated anti-mouse gd TCR (GL3), anti-
mouse ab TCR (H57-597), anti-CD3, anti-CD4, and anti-CD8.
Statistical analysis Data were expressed as the mean  SEM.
Statistical significances were assessed by Student’s t test, and
po0.05 was taken as the level of significance.
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